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We isolated a triterpenoid from an ethanolic extract of Phytolacca decandra and na-
noencapsulated it with biodegradable nontoxic polymers of poly(lactide-co-glycolide)
to examine if the nanoform of this hitherto unexplored betulinic-acid derivative (NdBA)
could produce a stronger anticancer effect by rendering better drug bioavailability and
targeted delivery than the nonencapsulated betulinic-acid derivative (dBA). The nano-
particles were characterized with the help of physicochemical and morphological
studies involving dynamic light scattering and atomic force microscopy. A549 cancer
cells were exposed to NdBA and dBA at the IC50 doses of 50 mg/mL and 100 mg/mL,
respectively. Mitochondrial dysfunction-mediated apoptosis was determined by exam-
ining the changes in the intracellular calcium content, the reactive oxygen species
accumulation, the cytochrome c release, the upregulation of Bcl-2-associated-X protein
(Bax) and caspase 3, the downregulation of B cell lymphoma 2, and the mitochondrial
membrane potential (DJm) depolarization. Apoptosis was also verified by acridine or-
ange staining observed under fluorescence microscopy and annexin V-fluorescein iso-




Anticancer action of nano-derivative of P. decandra 141intracellular adenosine triphosphate/adenosine diphosphate ratio decreased, and the
ATPase activity increased more strikingly in A549 cells exposed to NdBA than in A549
cells exposed to dBA. Overall results showed that both drugs directly target the mito-
chondrial oxidative phosphorylation system, with NdBA having a stronger effect, indi-
cating NdBA to be a better candidate for the development of an anticancer drug for
use against lung adenocarcinomas.1. Introduction
Cancer is one of the most dreaded diseases worldwide.
Lung cancer is a common cancer type, but still the pa-
tients continue to have a poor prognosis. As cancer cells
are endowed with the property of uncontrolled prolifer-
ation and growth, search for agents that can trigger
apoptosis or programmed cell death in tumor cells has
become a major goal in anticancer drug discovery [1]. In
response to apoptotic stimuli triggered by anticancer
drugs, several proteins (such as cytochrome c) are
released from the mitochondrial intermembrane space
into the cytoplasm that mediates the activation of cas-
pase cascades, which in turn ultimately promotes
apoptosis. Calcium is a key regulator of cell survival
because cytosolic free calcium concentration is a major
regulatory factor for large number of cellular processes
such as muscle contraction, secretion, cell differentia-
tion, and apoptosis. However, sustained elevation of
intracellular calcium plays a role in cell death as well [2].
The proapoptotic effects of calcium are mediated by a
diverse range of calcium-sensitive factors that are com-
partmentalized in various intracellular organelles,
including endoplasmic reticulum (ER) and mitochondria
[3]. Excessive calcium load to the mitochondria may
induce apoptosis by impairing mitochondrial function, for
example, generation of reactive oxygen species (ROS) by
damaged respiratory chain [4]. Calcium accumulation has
also been reported to stimulate mitochondrial ROS pro-
duction in cells [5,6]. Mitochondrial calcium uptake also
triggers significant membrane depolarization, resulting in
a decrease in the mitochondrial membrane potential [3].
Many plant-derived compounds are known to have
curative potentials against cancer [7e9]. The World Health
Organization estimated that approximately 80% of world’s
inhabitants rely mostly on traditional medicines for their
primary healthcare [10]. The root extract of Phytolacca
decandra, a plant commonly known as “Chui-Xu Shang-Lu”
in China, has been used for centuries as a traditional folk
medicine for the treatment of tumors, edema, bronchitis,
and abscesses [11]. Recently, we studied the anticancer
potentials of the ethanolic root extract of P decandra and
the nanoencapsulated form of the whole extract [8]. Yet,
no work had earlier been carried out on any of the major
ingredients contained in the crude ethanolic extract of PD
or the nanoencapsulated form of any such individual
ingredient. However, the extract of a congeneric species,
Phytolacca americana, has been reported to contain tri-
terpene saponins (phytolacca saponin), phytolaccagenic
acid, phytolaccagenin, etc. [12]. We isolated one of
the major ingredients of PD, namely, 1-isopropenyl-5a,5b,8,8,11a-pentamethyl-1,2,3,4,5,5a,6,7,7a,8,11,11a,
11b,12,13,13a,13b-octadecahydro cyclopenta[a]chrysene-
3a-carboxylic acid, which is presumably a derivative of
betulinic acid (dBA) and which had not been tested for its
anticancer potential. We therefore became interested to
study the possible anticancer efficacy of dBA and also
wanted to ascertain if the poly(lactide-co-glycolide) (PLGA)
nanoencapsulation of dBA (NdBA) could accentuate its
anticancer potential.
Therefore, the aims of the present study were to
determine: (1) if both dBA and NdBA induced apoptosis in
human lung adenocarcinoma (A549) cells in vitro, which
often defy any such chemotherapeutic venture; (2) if the
active ingredient and its nanoencapsulated form showed
any apoptotic ability, and whether NdBA had a stronger
effect than dBA; (3) if the apoptotic phenomenon was
associated with change in calcium content; and finally, (4)
if both dBA and NdBA modulated the intracellular calcium
content, to ascertain the possible role of Ca 2þ ion in the
mitochondrial apoptotic pathway.
2. Materials and methods
2.1. Reagents
All chemicals and reagents used in this study were pur-
chased from Sigma Chemical Co. (St. Louis, MO, USA).
2.2. Cell culture
Human nonsmall cell lung carcinoma A549 cells were pro-
cured from the National Center for Cell Science (Pune,
India). The cells were cultured at 5  105 cells/mL in Dul-
becco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum and 1% PSN antibiotic at 37 C, 5% CO2
for our experimental purpose.
2.3. Source of P decandra and identification of its
major bioactive component
The ethanolic root extract of P decandra used as homeo-
pathic mother tincture was manufactured and supplied by
Boiron Laboratories (Lyon, France). The ethanolic extract
was evaporated at 60 C (to remove alcohol from the
extract). The yield of the extract was about 52%; it was
isolated using the standard column chromatography
method over silica gel using a mixture of chloroform and
hexane (9:1) and was sent for mass spectroscopy, Fourier
transform infrared, and nuclear magnetic resonance ana-
lyses [8].
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loaded nanoparticles
For the PLGA encapsulation of dBA, the solvent displacement
technique [13] was deployed under optimal conditions,
which has been described elsewhere [8]. Following the same
method, blank nanoparticles were prepared without the
addition of dBA, and tested for its possible apoptotic effect
on A549. These blank nanomaterials failed to demonstrate
any apoptotic effect on A549, for which only dBA-loaded
nanoparticles were considered for further studies.
2.5. Atomic force microscopic studies of NdBA
Samples for atomic force microscopic (AFM) imaging were
prepared by dropping the NdBA suspension on a freshly
cleaned mica sheet and allowing it to dry in air. The
observation was recorded through AFM (Veeco di CP-11,
Plainview, NY, USA) imaging in amplitude and tapping
modes.
2.6. Particle size determination by dynamic light
scattering method
Determination of the average size and distribution of the
polymeric micelles were conducted using a dynamic light
scattering (DLS) machine (Malvern Instrument, South-
borough, UK) [8].
2.7. Cell proliferation assay
The viability of A549 cells was assessed by the MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
assay [14] after exposure to either dBA or NdBA. Cells were
seeded in 96-well plates at a density of 106 cells/mL and
were incubated with different concentrations of the drug
(25 mg/mL, 50 mg/mL, 75 mg/mL, and 100 mg/mL) for 24
hours. The intracellular formazan crystals formed were
solubilized with dimethyl sulfoxide, and the absorbance of
the solution was measured at 595 nm by using a microplate
reader (Thermo-Scientific, Multiskan ELISA, Waltham, USA).
The cell survival rate was calculated as percentage of MTT
inhibition by adopting the following formula: percentage of
survival Z (mean experimental absorbance/mean control
absorbance)  100%.
2.8. Surface morphological studies of A549 cells by
AFM
Control A549 cells and drug treated cells were first fixed in
a mixture of 2% paraformaldehyde and 2.5% glutaraldehyde
in 0.1 M phosphate buffer for 8 hours at 4 C, then dehy-
drated in increasing grades of ethanol (50e100%), and
finally dried and photographed by AFM (Veeco di CP-11).
2.9. Measurement of intracellular Ca2D content
Changes in [Ca2þ]i were assessed using the Ca
2þ-sensitive
fluorescent indicator dye Fura 2-AM (Santa Cruz Biotech-
nology, Inc., Texas, USA). The A549 cells were washed withcalcium free buffer [120 mM NaCl, 5 mM KCl, 1 mM MgSO4,
0.96 mM NaH2PO4, 0.2% glucose, 0.1% bovine serum albumin
(BSA), 20 mM HEPES, pHZ 7.2] and loaded with 6mM of Fura
2-AM at 37 C for 30 minutes. Cells were divided into two
parts: one was analyzed in a fluorimeter (PerkinElmer,
California, USA) and the other part was examined under a
fluorescent microscope (Leica, Wetzlar, Germany).
2.10. Determination of mitochondrial membrane
potential (Jm)
Changes in the mitochondrial membrane potential of con-
trol A549 cells and drug-treated groups were determined
using a fluorescent probe, Rhodamine 123, according to the
standard protocol [15]. Jm was assessed using flow
cytometry (FACS caliber, BD Bioscience, New Jersey, USA)
and fluorescence microscopy (Leica).
2.11. Assessment of mitochondrial adenosine
triphosphate/adenosine diphosphate ratio and
ATPase activity
The ratio of adenosine triphosphate/adenosine diphos-
phate (ATP/ADP) was measured using the Enzylight ADP/
ATP ratio bioluminescence assay kit (ELDT 100Q9) (CA, USA)
and assessed in a luminometer (Thermo-Scientific Varier
Skan) [16]. ATPase enzyme activity was determined by the
standard procedure [17] using phenol red indicator.
2.12. Microscopic analysis of intracellular ROS
Mitochondrial ROS was detected using the fluorescent
probe 20,70-dichlorofluorescein diacetate (DCFH-DA). DCFH-
DA is cell-permeable and is cleaved by nonspecific ester-
ases and oxidized by peroxides produced in the cells to
form fluorescent 20,70-dichlorofluorescin (DCF). The in-
tensity of DCF fluorescence is proportional to the amount of
peroxide produced in the cells. In brief, cells of different
treatment groups were incubated for 30 minutes with
DCFH-DA (5 mg/mL) at 37 C in the dark [18] and examined
with a fluorescence microscope (Leica, Germany).
2.13. Acridine Orange staining of apoptosis
Acridine Orange is a metachromatic dye that differentially
stains nucleic acids. Chromatin condensation is an early
event of apoptosis, and the condensed chromatin is much
more sensitive to DNA denaturation than normal chromatin.
The extent of apoptosis in drug A549 cells was determined
by acridine orange staining (1 mg/mL) preincubated with
RNase A (1 mg/mL), and the extent of fluorescence was
examined with a fluorescence microscope (Leica) [19].
2.14. Estimation of apoptotic% by flow cytometry
In order to evaluate apoptosis and necrosis, externalization
of phosphatidylserine during apoptosis and leakage from
necrotic cells was observed by annexin V-FITC/propidium
iodide (PI) dual staining using the standard protocol [19].
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tensity of 10,000 events.2.15. Immunoblot2.15.1. Preparation of cytosolic fraction
Control and drug-treated A549 cells were collected,
washed with ice-cold phosphate-buffered saline, resus-
pended in buffer A [10 mmol/L TriseMOPS pH 7.4,
200 mmol/L sucrose, 1 mmol/L ethylene glycol tetraacetic
acid (EGTA), 1 mg/mL BSA, 1 mmol/L dithiothreitol], and
lysed by homogenization. The suspension was centrifuged
at 1000  g for 10 minutes at 4 C. The resulting superna-
tant was centrifuged at 10,000  g for 15 minutes to pellet
mitochondria. Cytosolic fraction (supernatant) was ob-
tained by centrifugation at 12,000  g for 1 hour at 4 C.2.15.2. Isolation of mitochondria and preparation of
mitochondrial fraction
Mitochondria were isolated by harvesting A549 cells (of
different groups) with trypsin/EDTA, centrifuged at 300  g
for 5 minutes, washed in phosphate-buffered saline, and
resuspended in buffer A (10 mmol/L TriseMOPS pH 7.4,
200 mmol/L sucrose, 1 mmol/L EGTA, 1 mg/mL BSA,
1 mmol/L dithiothreitol). Cells were lysed with a homoge-
nizer (40 strokes), and the suspension was centrifuged at
2500  g for 10 minutes at 4 C. The supernatant was then
centrifuged at 10,000  g for 10 minutes at 4 C. The
resulting pellet was washed and resuspended in buffer B
(10 mmol/L TriseMOPS pH 7.4, 250 mmol/L sucrose,
1 mmol/L EGTA, 1 mg/mL BSA and 1 mmol/L phenyl-
methanesulfonyl fluoride).
The immunoblot analysis of both cytosolic and mito-
chondrial fractions was conducted by using anticytochrome c
and caspase3 antibodies (Santa Cruz Biotechnology). Alka-
line phosphatase-conjugated secondary antibodies (Sigma
Aldrich Inc. (St. Louis, MO, USA)) [20] were used for this
purpose. For quantitative analysis of each band, we deter-
mined the band intensity using the Total Lab software (Ultra
Lum, Claremone, CA, USA).2.16. RNA extraction and quantitative reverse
transcriptase-polymerase chain reaction analysis
Total RNA from A549 cells was extracted using Trizol re-
agent (procured from HiMedia, Mumbai, India) according to
the manufacturer’s instructions. cDNA was reverse tran-
scribed by reverse transcriptase and cDNA was used as a
template for polymerase chain reaction (PCR) amplification
with the aid of Taq polymerase as per the standard practice
[21]. Synthetic oligonucleotide primers for reverse tran-
scription (RT)-PCR were procured from Bioserve Biotech
(Hyderabad, India). The sequences of the forward and
reverse primers used for specific amplifications are as fol-
lows: G3PDH (50-ATGGGGAAGGTGAA-GGTCGG-30 and 50-
GGATGCTAAGCAGTTGGT-30); Bcl2 (50-TACCGTCGT-
GACTTCGCAGAG-30 and 50-GGCAGGCTGAGCAGGGTCTT-30);
Bax (50-CGGCGAATTGGAGATGAACTG-30 and 50-GCAAAGTA-
GAAGAGGGCAACC-30).2.17. In vivo assessment of relative absorption of
dBA and NdBA in various tissues
To determine the relative absorption potential of NdBA and
dBA, in various tissues, both drugs were orally administered
to mice for 7 days at a dose of 10 mg/kg body weight. At the
end of the treatment period, the mice were sacrificed, and
brain, lung, liver, and kidney tissues were dissected out,
homogenized in 2 mL ice-cold phosphate-buffered saline,
and diluted 100 times. The resulting diluted homogenates
were analyzed in a Spectrophotometer (Shimadzu, UVevi-
sible Spectrophotometer) at a wavelength of 479 nm (lmax).
Data were normalized with negative control (tissue from
saline-treated mice only).
3. Results
3.1. Mass spectroscopic studies of ethanolic extract
of Phytolacca decandra
The mass spectra value of the component with 80% occur-
rence was m/z Z 438.35 (Mþ), suggesting a triterpenoid
group, presumably a derivative of betulinic acid with the
molecular formula C30H46O2 (Fig. 1A),whichwas used as dBA.
3.2. Characterization of nanoparticles of NdBA
The surfacemorphology of NdBAwas spherical in shape, with
a smooth surface, but without any pinholes or cracks. Fig. 1B
and C show two- and three-dimensional images, respec-
tively, by atomic force microscopy. The mean diameter of
nanoparticles was found to be 110  0.5 nm, with a PDI
(Polydispersity index) of 0.254 and a zeta potential of
e17.6  0.24 mV. DLS data corroborated well with the AFM
result (Fig. 1D). The two-dimensional fast Fourier trans-
formation image (Fig. 1E) in AFM also showed the uniform
spatial frequency of the topographic planar signal of NdBA.
3.3. Cytotoxicity assay
The cell viability of A549 cells was examined after treatment
of dBA and NdBA at 24 hours. A dose-dependent cytotoxicity
was obtained. Although no apparent cytotoxic effect on cell
viability was observed at lower doses, the IC50 value of both
dBA and NdBA was found to be 50 mg/mL (Fig. 2A).
3.4. Morphology of A549 cells
A549 cells exposed to dBA and NdBA at doses of 50 mg/mL
and 100 mg/mL, respectively, showed at different fre-
quencies typical characteristics of apoptosis such as cell
blebbing, cytoplasmic shrinkage and detachment from each
other, floating in the medium, distortion, and nuclear
condensation (Fig. 2B).
3.5. Intracellular [Ca2D] content
To verify whether a calcium signal was involved in the
apoptosis pathway, the Ca2þ-sensitive dye Fura 2-AM was
used to investigate whether exposure to dBA and NdBA
Figure 1 Characterization of dBA and its nanoparticles (NdBA). (A) Mass spectroscopic analysis of dBA. (B) 2D image of NdBA by
AFM. (C) 3D image with mean diameter of NdBA by AFM. (D) Graphical data for DLS. (E) FFT spectra of NdBA. AFMZ atomic force
microscopy; dBA Z betulinic-acid derivative; DLS Z dynamic light scattering; FFT Z fast Fourier transform.
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Figure 2 Assessment of cell viability and measurement of [Ca2þ]i content. (A) Graphical representation of MTT assay to
determine IC50 value of dBA and NdBA. (B) Morphological studies in A549 cells by AFM after administration of dBA and NdBA after 24
hours of treatment. (C) Microscopic study of Fura 2-AM staining. (D) Fluorometric assessment of A549 cells. (a) Control A549; (b)
50 mg/mL dBA; (c) 100 mg/mL dBA; (d) 50 mg/mL NdBA; (e) 100 mg/mL NdBA. AFMZ atomic force microscopy; dBAZ betulinic-acid
derivative; MTT Z 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NdBA Z nanoform of dBA.
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Figure 3 Fluorescence microscopic and flow cytometric analyses of mitochondrial membrane potential (DJm), ATP/ADP ratio,
ATPase activity and generation of ROS. (A) Microscopic images of A549 cells for (DJm). (B) Flow cytometric analyses of (DJm). (C)
Graphical representation showing measurement of ATP/ADP ratio. (D) Graphical representation showing ATPase activity. (E)
Microscopic image of generation of ROS. (a) Control A549; (b) 50 mg/mL dBA; (c) 100 mg/mL dBA; (d) 50 mg/mL NdBA; (e) 100 mg/mL
NdBA. ATP/ADP ratioZ adenosine triphosphate/adenosine diphosphate ratio; dBAZ betulinic-acid derivative; NdBAZ nanoform
of dBA; ROS Z reactive oxygen species.
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increase in fluorescence intensity after exposure to 50 mg/
mL and 100 mg/mL of both dBA and NdBA in comparison to
the control (Fig. 2C and D).
3.6. Change in mitochondrial membrane potential
(DJm)
Compared with the control, dBA- and NdBA-treated cells
showed decrease in Rhodamine123 fluorescence intensity
with the increase in dBA and NdBA concentrations after 24
hours of incubation (Fig. 3A), with relatively more effective
mitochondrial membrane depolarization in NdBA-treated
A549 cells. A similar change was observed in dBA- and NdBA-
treated cellswhenalso analyzedflowcytometrically (Fig. 3B).3.7. ATP/ADP ratio and ATPse activity
The ATP/ADP ratio was found to have decreased in A549
cells with an increasing dose of dBA- and NdBA-treated cells
(Fig. 3C). Subsequently, a significant increase in the level of
ATPase activity was observed in dBA- and NdBA-treated
A549 cells (Fig. 3D).3.8. Generation of ROS
Generation of ROS was least in control A549 cells.
Compared to control, a significantly greater quantity of ROS
was generated when cells were treated with dBA and NdBA
(Fig. 3E).
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The control A549 cells showed green fluorescence, indi-
cating them to be viable, whereas dBA- and NdBA-treated
cells (100 mg/mL) showed red fluorescence with condensed
chromatin, indicating that they were undergoing apoptosis
(Fig. 4A).3.10. Estimation of apoptosis %
Data demonstrated that both dBA and NdBA stimulated
apoptosis (Annexin-positive cells) or necrosis (PI-positive
cells) in a dose-dependent manner. dBA increased the
proportion of early apoptotic cells from 0.5  0.42% (con-
trol A549 group) to 12.61  2.87% and 25.28  5.38% inFigure 4 Apoptosis%, immunoblot and RT-PCR. (A) Microscopic im
apoptosis. (C) Immunoblot of mitochondrial cyt C, cytosolic cyt C
In vivo assessment of effective absorption of dBA and NdBA in vari
dBA; (d) 50 mg/mL NdBA; (e) 100 mg/mL NdBA. Ln1Z control A549;
NdBA; Ln5Z 100 mg/mL NdBA. ap < 0.05, bp < 0.01, cp < 0.001 ve
acid derivative; NdBA Z nanoform of dBA; RT-PCR Z reverse tran50 mg/mL and 100 mg/mL, respectively. A similar result was
also obtained in NdBA-treated group, where the % of early
apoptotic cells was increased to 26.81  3.69% and
28.57  4.28% in 50 mg/mL and 100 mg/mL treatment
groups, respectively (Fig. 4B, aee).3.11. Immunoblot and RT-PCR studies
The expressions of protein were analyzed using the immu-
noblot technique (Fig. 4C, aee) and mRNA expression levels
by RT-PCR (Fig. 4D, aee) in different treated cells.
The expression level of cytochrome c in the mito-
chondrial fraction was found to be down-regulated with
increasing doses of dBA and NdBA, whereas the expres-
sion level of cytochrome c in cytosolic fraction was foundage of acridine orange staining. (B) Flow cytometric analysis of
, caspase 3 keeping b-actin as acting. (D) RT-PCR analysis. (E)
ous tissues. (a) Control A549; (b) 50 mg/mL dBA; (c) 100 mg/mL
Ln2Z 50 mg/mL dBA; Ln3Z 100 mg/mL dBA; Ln4Z 50 mg/mL
rsus control A549 cells for statistical analysis. dBAZ betulinic-
scription-polymerase chain reaction.
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NdBA.
The mRNA expression of Bcl-2-associated-X protein
(Bax) was up-regulated in a dose-dependent manner,
whereas that of Bcl2 was down-regulated in dBA- and
NdBA-treated cells. The expression of caspase 3 was
found to be up-regulated with increasing doses of dBA and
NdBA.Figure 5 Schematic representation of se3.12. Tissue distribution assay of PLGA
nanoparticles
The data revealed that most of the particles were detected
in the liver (45.4% NdBA and 40.9% dBA), followed by kidney
(16.6% NdBA and 10.98% dBA), lung (14.67% NdBA and 8.31%
dBA), and brain (3.88% NdBA and 0% dBA) in all 7 days
(Fig. 4E) of the study.quence of events leading to apoptosis.
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We demonstrated in this study that both dBA and NdBA
decreased the viability of A549 cells in a dose-dependent
manner. Both drugs accomplished this task mainly through
induction of apoptosis via ER stress and Ca2þ-associated
mitochondria-dependent pathway. Therefore, we first
attempted to identify the molecular mechanisms involved
in dBA- and NdBA-induced apoptosis. Our main focus was
then shifted toward understanding the possible role of al-
terations in Ca2þ homeostasis induced by both dBA and
NdBA. Such an approach seems to have not been made by
any other workers earlier in respect of these drugs. It is
known that the apoptotic process is preceded by the
collapse of the mitochondrial potential, which could be
triggered by multiple stimuli such as changes in Ca2þ, ox-
ygen radicals, swelling of the matrix and rupture of the
outer membrane with ensuing changes in the permeability
of the outer mitochondrial membrane, and release of
apoptogenic factors. Results of the present study indicated
that the intracellular calcium ([Ca2þ]i) concentration
increased significantly after the administration of both dBA
and NdBA. Pretreatment with EGTA (Ca2þ chelator) did not
prevent the increase of [Ca2þ]i, which indicated that the
calcium was from an intracellular store and not from an
extracellular store. Ca2þ release from the ER is known to be
apoptogenic [22], which ultimately leads to the loss of
[Ca2þ]i homeostasis, and associated with cellular
apoptosisda common mechanism of cell death [23]. In this
regard, results of our studies are in conformity with those
of Yang et al [24] and Gao et al [25], indicating that loss of
Ca2þ from ER lumen plays an important role in exerting the
cytotoxic effects of dBA and NdBA, presumably by inducing
acute ER stress.
dBA and NdBA treatments also caused breakdown of the
oxidative phosphorylation system by ATP/ADP ratio deple-
tion and dissipation of DJm and elevation of ROS, indi-
cating that dBA could target mitochondria; however, it was
noted that NdBA acted more effectively compared to dBA.
Disruption of DJm leads to mitochondrial permeabilization
that commonly accompanies or precedes the release of
cytochrome c into the cytoplasm, leading to the formation
of an active apoptosome complex and the activation of
caspase cascade, which then activates the executioner
caspase3 to orchestrate apoptosis [26].
Our result showed that intracellular ROS levels were
significantly increased in a dose-dependent manner after
administration of dBA and NdBA. However, the relationship
between intracellular calcium and oxidative stress may be
complex, because oxidative stress initiates changes in cal-
cium concentrations in cells, which may subsequently
activate the production of ROS.
Marked chromatin condensation and apoptotic body
formation in dBA- and NdBA-treated cells were also
observed in cells after the administration of the highest
dose (100 mg/mL). The annexin V-FITC/PI assay revealed
that early and late apoptotic percentages after NdBA
treatments (50 mg/mL and 100 mg/mL) were significantly
higher than those of dBA-treated ones. The result suggests
that there is a possibility that both dBA and NdBA promoted
the levels of ER stress associated proteins and increased theexpression of Bax and also inhibited the levels of Bcl2,
resulting in disruption of the mitochondrial membrane po-
tential and subsequent release of cytochrome c from
mitochondria to cytosol. This was followed by caspase3
activation that finally resulted in apoptosis of A549 cells. A
schematic representation of the possible sequence of
events is summarized in Fig. 5.
In order to examine if the nanoencapsulated ingredient
could readily enter different organ systems of living animals
in vivo faster than the dBA, the relative distribution of the
drugs was assessed in different organ systems of mice,
having a close resemblance to the human system, for
extrapolation. The result confirmed that NdBA entered
faster than dBA inside all tissues, including the lung, and
could also cross the bloodebrain barrier. This qualifies
NdBA to be a better candidate and a more potent anti-
cancer drug for lung cancer, as it provided a better efficacy
in drug delivery. This information can be of considerable
help in future drug development and in the therapeutic
management of human lung cancer. However, prior to when
it can be recommended for practical use, more animal
experiments are necessary to confirm if it has a similar
efficacy in other mammalian models.
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